Mobile Media-Rich Interactive Guideline System (MMRIGS) Pilot Study

Tobacco Use Cessation Clinical Trial

Official title:

Mobile Smoking Cessation Treatment for Underserved Smokers: A Pilot and Feasibility Study

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02302859
• Other study ID #: 2014-0509
• Secondary ID: NCI-2014-02572
• Status: Terminated
• Phase: N/A
• Start date: January 2015
• Est. completion date: March 2016

Study information

• Verified date: January 2020
• Source: M.D. Anderson Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this research study is to learn about 2 different interactive methods that are designed to help people with HIV/AIDS stop smoking.

Description:

Baseline Questionnaire:

If you agree to take part in this study, you will complete a questionnaire on a laptop about your feelings, mood, health, thoughts about smoking, thoughts about quitting smoking, smoking history, and some demographic information such as age, education level, and income level. This should take about 15-20 minutes to complete.

Study Groups:

After completing the questionnaire, you will be randomly assigned (as in the flip of a coin) to 1 of 2 study groups. You will have an equal chance of being placed in either group.

Both groups will receive smart phones and an 8-week supply of nicotine patches with instructions on how to use them. Each group will receive different methods of advice for quitting smoking.

If you are assigned to Group 1, the following study procedures will be performed:

• You will receive brief advice on how to quit smoking once at the time of enrollment. The advice will be given from a pamphlet that has information such as health problems related to smoking, how many Americans are affected each year, financial problems related to smoking, nicotine replacement therapy options, preparation for quitting smoking, and encouragement to quit.

• On the smart phone, you will have 5 phone counseling sessions for support in quitting smoking throughout the 8-week intervention treatment. The calls should last about 15 minutes.

If you are assigned to Group 2, the following study procedures will be performed:

• On the smart phone, you will receive brief video clips with advice on how to quit smoking, as well as interactive text and picture messages once a week for 8 weeks. The video clips will be about 5 minutes long.

• You will also have access to additional counseling content on the smart phone, which you can use at any time.

Weekly Smart Phone Questionnaires:

Both groups will complete questionnaires on the smart phone every week for 8 weeks. Each questionnaire will have questions about your current smoking status, your motivation level to stop smoking, and things that may have a negative effect on your quitting. The questionnaire should take about 15 minutes to complete.

Follow-up Saliva Test and Questionnaire:

About 3 months after your first smart phone intervention, both groups will complete a saliva test and take a photograph of the test results. The saliva test results will be used to check your smoking activity. Supplies and instructions will be given to you when you are enrolled on the study and the instructions will be available on the smart phone. You will also complete a questionnaire similar to the baseline questionnaire.

Length of Study:

You will be on study for about 3 months.

This is an investigational study. Up to 50 participants will take part in this study. All will be enrolled at the Harris Health System (Thomas Street Health Center).

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 8
• Est. completion date: March 2016
• Est. primary completion date: March 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. 18 years of age or older

2. Smoked at least 100 cigarettes in lifetime

3. English speaking

4. HIV-positive patient at Thomas Street Health Center

5. Currently smoking 5 or more cigarettes per day

6. Willing to make a quit attempt within 1 week of enrollment

Exclusion Criteria:

1. Positive history of a medical condition that precludes use of the nicotine patch

2. Current use of nicotine replacement therapy (NRT)

3. Current use of other smoking cessation medications (e.g., Chantix or Zyban)

4. Pregnant or nursing

5. Enrolled in another smoking cessation study

Related Conditions & MeSH terms

• Tobacco Use Cessation

Intervention

Drug:
• Nicotine Patch
Participants receive an 8 week supply of Nicotine patches.

Behavioral:
• Questionnaires
Questionnaire completion at baseline on laptop, then weekly for 8 weeks on smartphone, then 3 months after smartphone intervention.

Other:
• Pamphlet
Pamphlet given to participant describing health and financial reasons to quit smoking.

Behavioral:
• Phone Counseling Sessions
Standard Treatment (ST) Group: Participants receive 8 phone counseling sessions (one session per week) for support in quitting smoking. The calls should last about 15 minutes. Automated Treatment (AT) Group: Participants receive brief video clips with advice on how to quit smoking over smartphone, as well as interactive text and picture messages once a week for 8 weeks. The video clips will be about 5 minutes long. Participants also have access to additional counseling content on the smart phone, which can be used at any time.

Other:
• Saliva Test
Participants complete saliva cotinine test 3 months after intervention.

Device:
• Smart phone
Standard Treatment (ST) Group: Participants receive proactive phone counseling (8 sessions) over the 8-week period for support in quitting smoking. The call will last about 15 minutes. Automated Treatment (AT) Group: Participants receive brief advice to quit smoking (tailored video clips) and an 8-week automated intervention (interactive text messages and graphical messages) for support in quitting smoking via smartphone.

Locations

Country	Name	City	State
United States	Thomas Street Health Center -Harris Health System	Houston	Texas

Sponsors (1)

Lead Sponsor	Collaborator
M.D. Anderson Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Smoking Abstinence: 3-month Assessment Via Smart Phone	Smoking abstinence defined as number of participants with biochemically 7-day abstinence confirmed with weekly smart-phone assessments. Saliva cotinine levels, assessed with NicAlert test strips, used to biochemically verify abstinence. Participants will complete the NicAlert saliva cotinine test (supplies given at enrollment) and take a photograph of the test strip results. In primary abstinence analysis for difference in cessation rate between interventions, participants who do not complete follow-up assessments considered to be smokers.	3 months

External Links

•   University of Texas MD Anderson Cancer Center Website